Recombinant Human coronavirus SARS-CoV-2 Spike Glycoprotein S2 (Fc Chimera) is a Fragment protein, in the 685 to 1211 aa range, expressed in HEK 293, with >90% purity, < 1 EU/mL endotoxin level and suitable for SDS-PAGE.
T Q T N S P R R A R S V A S Q S I I A Y T M S L G A E N S V A Y S N N S I A I P T N F T I S V T T E I L P V S M T K T S V D C T M Y I C G D S T E C S N L L L Q Y G S F C T Q L N R A L T G I A V E Q D K N T Q E V F A Q V K Q I Y K T P P I K D F G G F N F S Q I L P D P S K P S K R S F I E D L L F N K V T L A D A G F I K Q Y G D C L G D I A A R D L I C A Q K F N G L T V L P P L L T D E M I A Q Y T S A L L A G T I T S G W T F G A G A A L Q I P F A M Q M A Y R F N G I G V T Q N V L Y E N Q K L I A N Q F N S A I G K I Q D S L S S T A S A L G K L Q D V V N Q N A Q A L N T L V K Q L S S N F G A I S S V L N D I L S R L D K V E A E V Q I D R L I T G R L Q S L Q T Y V T Q Q L I R A A E I R A S A N L A A T K M S E C V L G Q S K R V D F C G K G Y H L M S F P Q S A P H G V V F L H V T Y V P A Q E K N F T T A P A I C H D G K A H F P R E G V F V S N G T H W F V T Q R N F Y E P Q I I T T D N T F V S G N C D V V I G I V N N T V Y D P L Q P E L D S F K E E L D K Y F K N H T S P D V D L G D I S G I N A S V V N I Q K E I D R L N E V A K N L N E S L I D L Q E L G K Y E Q Y I K
Application | Reactivity | Dilution info | Notes |
---|---|---|---|
Application SDS-PAGE | Reactivity Reacts | Dilution info - | Notes - |
SARS-CoV-2 Spike Glycoprotein S2
Recombinant Human coronavirus SARS-CoV-2 Spike Glycoprotein S2 (Fc Chimera) is a Fragment protein, in the 685 to 1211 aa range, expressed in HEK 293, with >90% purity, < 1 EU/mL endotoxin level and suitable for SDS-PAGE.
pH: 7 - 8
Constituents: PBS
The SARS-CoV-2 Spike Glycoprotein S2 also known as S2 subunit is a segment of spike protein found on the surface of the SARS-CoV-2 virus. The spike protein facilitates viral entry into host cells. Mechanically S2 mediates membrane fusion which is essential for the virus to merge with cellular membranes allowing viral RNA to enter and replicate within the host. This protein has a molecular weight of approximately 680 kDa combined with S1. Expressed mainly in virions the spike protein is the target for many therapeutic interventions.
The SARS-CoV-2 Spike Glycoprotein S2 plays an important role in the viral infectivity process. It is part of a trimeric spike protein complex which undergoes a conformational shift during host cell entry. The S2 subunit specifically triggers the fusion process following receptor binding of another component the S1 subunit. During infection immune response typically generates anti-spike antibodies that target this protein aiming to block viral invasion or clear infected cells.
The SARS-CoV-2 Spike Glycoprotein S2 is critical in the viral entry and replication pathway. It interacts with host proteins in pathways involving endocytosis. The fusion activity of S2 is closely associated with cellular proteases like TMPRSS2 and furin which prime the spike protein for entry. These interactions are important for the initiation of the viral replication cycle and help shape the host's pathophysiological response to infection.
The SARS-CoV-2 Spike Glycoprotein S2 holds significant relevance in COVID-19 pathogenesis which is caused by the SARS-CoV-2 virus. This protein's interaction with angiotensin-converting enzyme 2 (ACE2) alongside the spike S1 subunit plays an important role in determining the virus’s infectivity and host cell invasion. Understanding its role can aid in designing therapeutic strategies against COVID-19 and related variants also revealing connections to host immune responses.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
SDS-PAGE analysis of ab272106.
**Lane 1: **Red - loading control Donkey anti-Goat IgG H&L (IRDye® 800CW) preadsorbed (Donkey anti-Goat IgG H&L (IRDye® 800CW) preadsorbed ab216775) binding to the sheep Fc Chimera tag on recombinant human coronavirus SARS-CoV-2 spike glycoprotein S2 - observed at 135 kDa
**Lanes 2: **Green - Anti-SARS-CoV-2 Spike Glycoprotein S2 antibody [EPR25038-122] ab283913 observed at 135 kDa.
Anti-SARS-CoV-2 Spike Glycoprotein S2 antibody [EPR25038-122] ab283913 was shown to bind specifically to SARS-CoV-2 spike glycoprotein S2 in Western blot. Samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Donkey anti-Goat IgG H&L (IRDye® 800CW) preadsorbed (Donkey anti-Goat IgG H&L (IRDye® 800CW) preadsorbed ab216775) and Donkey anti-Rabbit IgG H&L (IRDye® 680RD) preadsorbed (Donkey Anti-Rabbit IgG H&L (IRDye® 680RD) preadsorbed ab216779) at 1/20000 dilution.
Blocking buffer: 3% milk in TBS-0.1% Tween® 20 (TBS-T)
All lanes: Western blot - Anti-SARS-CoV-2 Spike Glycoprotein S2 antibody [EPR25038-122] (Anti-SARS-CoV-2 Spike Glycoprotein S2 antibody [EPR25038-122] ab283913) at 1/1000 dilution
Lane 1: Western blot - Recombinant Human coronavirus SARS-CoV-2 Spike Glycoprotein S2 (Fc Chimera) (ab272106) at 2 µg
Lane 2: Western blot - Recombinant Human coronavirus SARS-CoV-2 Spike Glycoprotein S2 (Fc Chimera) (ab272106) at 0.2 µg
Lane 1: Western blot - Donkey anti-Goat IgG H&L (IRDye® 800CW) preadsorbed (Donkey anti-Goat IgG H&L (IRDye® 800CW) preadsorbed ab216775)
Lane 2: Western blot - Donkey Anti-Rabbit IgG H&L (IRDye® 680RD) preadsorbed (Donkey Anti-Rabbit IgG H&L (IRDye® 680RD) preadsorbed ab216779) at 1/20000 dilution
Observed band size: 135 kDa
This data was developed using Anti-SARS-CoV-2 Spike Glycoprotein S2 antibody [EPR25038-122] ab283913, the same antibody clone in a different buffer formulation.
**Lane 1: **Red - loading control Donkey anti-Goat IgG H&L (IRDye® 800CW) preadsorbed (Donkey anti-Goat IgG H&L (IRDye® 800CW) preadsorbed ab216775) binding to the sheep Fc Chimera tag on recombinant human coronavirus SARS-CoV-2 spike glycoprotein S2 - observed at 135 kDa
**Lanes 2: **Green - Anti-SARS-CoV-2 Spike Glycoprotein S2 antibody [EPR25038-122] ab283913 observed at 135 kDa.
Anti-SARS-CoV-2 Spike Glycoprotein S2 antibody [EPR25038-122] ab283913 was shown to bind specifically to SARS-CoV-2 spike glycoprotein S2 in Western blot. Samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Donkey anti-Goat IgG H&L (IRDye® 800CW) preadsorbed (Donkey anti-Goat IgG H&L (IRDye® 800CW) preadsorbed ab216775) and Donkey anti-Rabbit IgG H&L (IRDye® 680RD) preadsorbed (Donkey Anti-Rabbit IgG H&L (IRDye® 680RD) preadsorbed ab216779) at 1/20000 dilution.
**Blocking buffer: **3% milk in TBS-0.1% Tween® 20 (TBS-T)
All lanes: Western blot - Anti-SARS-CoV-2 Spike Glycoprotein S2 antibody [EPR25038-122] - BSA and Azide free (Anti-SARS-CoV-2 Spike Glycoprotein S2 antibody [EPR25038-122] - BSA and Azide free ab284041)
All lanes: Western blot - Recombinant Human coronavirus SARS-CoV-2 Spike Glycoprotein S2 (Fc Chimera) (ab272106) at 0.2 µg
Lane 1: Western blot - Donkey anti-Goat IgG H&L (IRDye® 800CW) preadsorbed (Donkey anti-Goat IgG H&L (IRDye® 800CW) preadsorbed ab216775)
Lane 2: Western blot - Donkey anti-Goat IgG H&L (IRDye® 800CW) preadsorbed (Donkey anti-Goat IgG H&L (IRDye® 800CW) preadsorbed ab216775) at 1/20000 dilution
Indirect ELISA showing primary antibody Anti-SARS-CoV-2 Spike Glycoprotein S1 antibody [8B12-C2] - Chicken IgY (Chimeric) ab322999 binding to Recombinant Human coronavirus SARS-CoV-2 Spike Glycoprotein S1 (Fc Chimera, Recombinant Human coronavirus SARS-CoV-2 Spike Glycoprotein S1 (Fc Chimera) ab272105). Plates were coated with Recombinant Human coronavirus SARS-CoV-2 Spike Glycoprotein S1 (Fc Chimera, Recombinant Human coronavirus SARS-CoV-2 Spike Glycoprotein S1 (Fc Chimera) ab272105), Recombinant Human coronavirus SARS-CoV-2 Spike Glycoprotein S2 (Fc Chimera, ab272106) and Recombinant Human coronavirus SARS spike glycoprotein (Tagged, Recombinant Human coronavirus SARS spike glycoprotein (Tagged) ab270844) at 1000 ng/ml. Binding of Anti-SARS-CoV-2 Spike Glycoprotein S1 antibody [8B12-C2] - Chicken IgY (Chimeric) ab322999 was assessed in a serial dilution range 0.016- 1000 ng/mL (a 3-fold serial dilution). Secondary antibody, Goat Anti-Chicken IgY H&L (HRP, Goat Anti-Chicken IgY H&L (HRP) ab6877) was used at 1:5000.
Indirect ELISA showing primary antibody Anti-SARS-CoV-2 Spike Glycoprotein S1 antibody [EPR24852-116] - Human IgG1 (Chimeric) ab323000 binding to Recombinant Human coronavirus SARS-CoV-2 Spike Glycoprotein S1 (Fc Chimera, Recombinant Human coronavirus SARS-CoV-2 Spike Glycoprotein S1 (Fc Chimera) ab272105). Plates were coated with Recombinant Human coronavirus SARS-CoV-2 Spike Glycoprotein S1 (Fc Chimera, Recombinant Human coronavirus SARS-CoV-2 Spike Glycoprotein S1 (Fc Chimera) ab272105), Recombinant Human coronavirus SARS-CoV-2 Spike Glycoprotein S2 (Fc Chimera, ab272106) and Recombinant human coronavirus SARS spike glycoprotein (Tagged, Recombinant Human coronavirus SARS spike glycoprotein (Tagged) ab270844) at 1000 ng/ml. Binding of Anti-SARS-CoV-2 Spike Glycoprotein S1 antibody [EPR24852-116] - Human IgG1 (Chimeric) ab323000 was assessed in a serial dilution range 0.016- 1000 ng/mL (a 3-fold serial dilution). Secondary antibody, Goat Anti-Human IgG Fc (HRP) preadsorbed (Goat Anti-Human IgG Fc (HRP) preadsorbed ab98624) was used at 1:5000.
Dot blot analysis using Anti-SARS-CoV-2 Spike Glycoprotein S2 antibody [EPR25038-122] ab283913 at 1/1000 dilution followed by a Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution.
Lane 1: Recombinant Human coronavirus SARS-CoV-2 (B.1.1.529/Omicron) Spike Glycoprotein S1 (Recombinant Human coronavirus SARS-CoV-2 (B.1.1.529/Omicron) Spike Glycoprotein S1 ab290828).
Lane 2: Recombinant Human coronavirus SARS-CoV-2 (B.1.1.529/Omicron) Spike Glycoprotein S1 RBD protein (Recombinant Human coronavirus SARS-CoV-2 (B.1.1.529/Omicron) Spike Glycoprotein S1 RBD protein ab290829).
Lane 3: Recombinant Human coronavirus SARS-CoV-2 (B.1.1.529/Omicron) Spike protein.
Lane 4: Recombinant Human coronavirus SARS-CoV-2 Spike Glycoprotein S2 (ab272106).
Blocking buffer and concentration: 5% NFDM/TBST.
Diluting buffer and concentration: 5% NFDM/TBST.
Exposure Time: 180 seconds.
Indirect ELISA showing primary antibody Anti-SARS-CoV-2 Spike Glycoprotein S1 [8B12-C2] – Human IgG1 (Chimeric) ab322272 binding to Recombinant Human coronavirus SARS-CoV-2 Spike Glycoprotein S1 (Fc Chimera, Recombinant Human coronavirus SARS-CoV-2 Spike Glycoprotein S1 (Fc Chimera) ab272105). Plates were coated with Recombinant Human coronavirus SARS-CoV-2 Spike Glycoprotein S1 (Fc Chimera, Recombinant Human coronavirus SARS-CoV-2 Spike Glycoprotein S1 (Fc Chimera) ab272105) and Recombinant Human coronavirus SARS-CoV-2 Spike Glycoprotein S2 (Fc Chimera, ab272106) at 1000 ng/ml. Binding of Anti-SARS-CoV-2 Spike Glycoprotein S1 [8B12-C2] – Human IgG1 (Chimeric) ab322272 was assessed in a serial dilution range 0.016- 1000 ng/mL (a 3-fold serial dilution). Secondary antibody, Goat Anti-Human IgG Fc (HRP) preadsorbed (Goat Anti-Human IgG Fc (HRP) preadsorbed ab98624) was used at 1:5000.
Indirect ELISA showing primary antibody Anti-SARS-CoV-2 Spike Glycoprotein S2 antibody [EPR25038-122] ab283913 binding SARS-CoV-2 (Omicron variant) Spike Glycoprotein S1 (Recombinant Human coronavirus SARS-CoV-2 (B.1.1.529/Omicron) Spike Glycoprotein S1 ab290828); SARS-CoV-2 (Omicron variant) Spike Glycoprotein RBD (Recombinant Human coronavirus SARS-CoV-2 (B.1.1.529/Omicron) Spike Glycoprotein S1 RBD protein ab290829); Recombinant SARS-CoV-2 Omicron variant Spike protein (GCN4-IZ) His tag; Recombinant Human coronavirus SARS-CoV-2 Spike Glycoprotein S2 (Fc Chimera) (ab272106). Antigen concentration is 1000 ng/ml. Substrate solution is p-nitrophenyl phosphate(PNPP).
Binding of Anti-SARS-CoV-2 Spike Glycoprotein S2 antibody [EPR25038-122] ab283913 was assessed in a serial dilution range 1000-0 ng/ml.
Binding was detected using the secondary antibody, Alkaline Phosphatase-conjugated AffiniPure Goat Anti-Rabbit IgG(H+L) at 1/2500 dilution.
Indirect ELISA showing primary antibody Anti-SARS-CoV-2 Spike Glycoprotein S1 antibody [EPR24852-116] - Chicken IgY (Chimeric) ab323001 binding to Recombinant Human coronavirus SARS-CoV-2 Spike Glycoprotein S1 (Fc Chimera, Recombinant Human coronavirus SARS-CoV-2 Spike Glycoprotein S1 (Fc Chimera) ab272105). Plates were coated with Recombinant Human coronavirus SARS-CoV-2 Spike Glycoprotein S1 (Fc Chimera, Recombinant Human coronavirus SARS-CoV-2 Spike Glycoprotein S1 (Fc Chimera) ab272105), Recombinant Human coronavirus SARS-CoV-2 Spike Glycoprotein S2 (Fc Chimera, ab272106) and Recombinant Human coronavirus SARS spike glycoprotein (Tagged, Recombinant Human coronavirus SARS spike glycoprotein (Tagged) ab270844) at 1000 ng/ml. Binding of Anti-SARS-CoV-2 Spike Glycoprotein S1 antibody [EPR24852-116] - Chicken IgY (Chimeric) ab323001 was assessed in a serial dilution range 0.016- 1000 ng/mL (a 3-fold serial dilution). Secondary antibody, Goat Anti-Chicken IgY H&L (HRP, Goat Anti-Chicken IgY H&L (HRP) ab6877) was used at 1:5000.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com